Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.
Rossi A, Lin SXN, Absalom NL, Ortiz-De la Rosa S, Liao VWY, Mohammadi NA, Viswanathan S, Stödberg T, Danieli A, Bonanni P, Aeby A, Orsini A, Bonuccelli A, Rüegger A, Giraldez BG, Isidor B, Stüve B, Marini C, Cesaroni E, Fenger CD, Philippe C, Meunier C, Lederer D, Moortgat S, Spinelli E, Fallica E, Zeiner F, Bauman M, Licchetta L, Bisulli F, Operto FF, Benkel-Herrenbrueck I, Gorman KM, Johannesen KM, Platzer K, Schnabel F, Lagae L, Laufs M, Zordania R, Malone S, Messana T, Werckx W, Jonsson C, Afawi Z, Foiadelli T, Halleb Y, Stoeva R, Jennesson-Lyver M, Lesca G, Guerrini R, Berkovic SF, Scheffer IE, Chebib M, Gardella E, Møller RS, Rubboli G, Ahring PK. Rossi A, et al. Among authors: fallica e. Neurology. 2025 Jul 22;105(2):e213644. doi: 10.1212/WNL.0000000000213644. Epub 2025 Jun 26. Neurology. 2025. PMID: 40570274 Free PMC article.
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants.
Muccioli L, Bisulli F, Minardi R, Valentino ML, De Simone M, Paroni RA, Cesnik E, Fallica E, Bonan L, Pizzi E; DEFEAT‐LD Study Group; Cantalupo G, Licchetta L. Muccioli L, et al. Among authors: fallica e. Epilepsia Open. 2025 Sep 26. doi: 10.1002/epi4.70104. Online ahead of print. Epilepsia Open. 2025. PMID: 41003650 Free article.
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study.
Lattanzi S, Dono F, d'Orsi G, D'Aniello A, Panebianco M, Bonanni P, Di Bonaventura C, Montalenti E, Gambardella A, Ranzato F, Pauletto G, Tartara E, La Neve A, Bisulli F, Vatti G, Pulitano P, Liguori C, Assenza G, Giordano A, Pignatta P, Belcastro V, Cecconi M, Beretta S, Pizzanelli C, Pezzella M, Gangitano M, Elia M, Renna R, Vollono C, Pascarella A, Tramacere L, De Maria G, Audenino D, Pasolini MP, Giuliano L, Galli R, Strigaro G, Puligheddu M, Labate A, Penza P, Quadri S, Stokelj D, Boero G, Fallica E, Santo Sabato M, Falcicchio G, Foschi N, Procaccini M, Villano V, Camattari G, Mele F, Roncari B, Di Gennaro G; BLESS Study Group. Lattanzi S, et al. Among authors: fallica e. Epilepsia. 2025 Jul;66(7):2239-2252. doi: 10.1111/epi.18357. Epub 2025 Mar 15. Epilepsia. 2025. PMID: 40088187 Free PMC article.
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study.
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) Group Membership. Lattanzi S, et al. Neurol Ther. 2025 Jun;14(3):775-786. doi: 10.1007/s40120-025-00717-x. Epub 2025 Mar 12. Neurol Ther. 2025. PMID: 40069539 Free PMC article.
Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia-Romagna region, Italy.
Di Vito L, Matteo E, Meletti S, Zenesini C, Bernabè G, Bomprezzi C, Casadio MC, Castioni CA, Cesnik E, Coniglio C, Currò-Dossi M, De Massis P, Fallica E, Florindo I, Giovannini G, Guarino M, Marchesi E, Marudi A, Merli E, Monti G, Orlandi N, Pasini E, Passarelli D, Rinaldi R, Rizzi R, Romoli M, Santangelo M, Tontini V, Turchi G, Volpini M, Zini A, Zinno L, Michelucci R, Vignatelli L, Tinuper P, Bisulli F; STEPPER study group. Di Vito L, et al. Among authors: fallica e. Epilepsia. 2025 Mar;66(3):753-767. doi: 10.1111/epi.18227. Epub 2024 Dec 21. Epilepsia. 2025. PMID: 39707958 Free PMC article.
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology).
Michelucci R, Pasini E, Meletti S, Fallica E, Rizzi R, Florindo I, Chiari A, Monetti C, Cremonini AM, Forlivesi S, Albani F, Baruzzi A; PERNO Study Group. Michelucci R, et al. Among authors: fallica e. Epilepsia. 2013 Oct;54 Suppl 7:86-91. doi: 10.1111/epi.12314. Epilepsia. 2013. PMID: 24099060 Review.
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership. Lattanzi S, et al. Drugs Aging. 2022 Apr;39(4):297-304. doi: 10.1007/s40266-022-00931-4. Epub 2022 Mar 28. Drugs Aging. 2022. PMID: 35344198 Free PMC article.
38 results